To read this content please select one of the options below:

Appropriate polypharmacy: a barometer for integrated care

Alpana Mair (Effective Medicine and Therapeutics Division, Scottish Government, Edinburgh, UK )
Eleftheria Antoniadou (Rehabilitation Clinic, University General Hospital of Patras, Patras, Greece)
Anne Hendry (Research, NHS Lanarkshire, Airdrie, UK) (Health and Life Sciences, University of the West of Scotland, Paisley, UK)
Branko Gabrovec (Centre for Health Care, National Institute of Public Health of the Republic of Slovenia, Ljubljana, Slovenia)

Journal of Integrated Care

ISSN: 1476-9018

Article publication date: 18 December 2020

Issue publication date: 1 April 2021

177

Abstract

Purpose

Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven by an ageing population and the growing number of people living longer with chronic conditions. Up to 11% of unplanned hospital admissions in the UK are attributable to, mostly avoidable, harm from medicines. However, this topic is not yet central to integrated practice. This paper reviews the challenge that polypharmacy presents to the health and care system and offers lessons for integrated policy and practice.

Design/methodology/approach

Two commonly encountered scenarios illustrate the relevance of addressing inappropriate polypharmacy to integrated practice. An overview of the literature on polypharmacy and frailty, including two recent large studies of policy and practice in Europe, identifies lessons for practitioners, managers, policy makers and commissioners.

Findings

Comprehensive change strategies should extend beyond pharmacist led deprescribing initiatives. An inter-professional and systems thinking approach is required, so all members of the integrated team can play their part in realising the value of holistic prescribing, appropriate polypharmacy and shared decision making.

Practical implications

Awareness and education about polypharmacy should be embedded in inter-professional training for all practitioners who care for people with multimorbidity or frailty.

Originality/value

This paper will help policy makers, commissioners, managers and practitioners understand the value of addressing polypharmacy within their integrated services. Best practice national guidance developed in Scotland illustrates how to target resources so those at greatest risk of harm from polypharmacy can benefit from effective pharmaceutical care as part of holistic integrated care.

Keywords

Acknowledgements

The authors would like to thank colleagues from ADVANTAGE JA and SIMPATHY projects, both co-funded by the European Commission CHAFEA Health Program, and the Scottish Polypharmacy guidance (2018) Model of Care group.

Citation

Mair, A., Antoniadou, E., Hendry, A. and Gabrovec, B. (2021), "Appropriate polypharmacy: a barometer for integrated care", Journal of Integrated Care, Vol. 29 No. 2, pp. 204-214. https://doi.org/10.1108/JICA-04-2020-0019

Publisher

:

Emerald Publishing Limited

Copyright © 2020, Emerald Publishing Limited

Related articles